Hep C - Rigel Granted Key Patents in Immunology, Virology and Oncology

Rigel Granted Key Patents in Immunology, Virology and Oncology
Black Enterprise, NY - Mar 21, 2006... Rigel was granted six patents in immunology, five patents related to its ubiquitin ligase technology, four patents related to hepatitis-C (HCV), six patents in ...

Human Genome tumbles on mixed drug data
MarketWatch - Mar 14, 2006... Albuferon is being tested in combination with the antiviral ribavirin to see if it can reduce levels of the hepatitis C virus, or HCV, in both patients who ...

Genelabs Technologies Reports 2005 Year-End and Fourth Quarter ...
Yahoo! News (press release) - Apr 3, 2006... We advanced two distinct classes of non- nucleoside compounds with potent activity against the HCV polymerase in preclinical development. ...

ViroPharma's Generic Discount
MSNBC - Mar 20, 2006... from GlaxoSmithKline(NYSE: GSK) in 2003, is used to treat cytomegalovirus, a common virus in the herpes family that is found worldwide; and HCV-796, with which ...